期刊文献+

基底细胞样乳腺癌组织中Apaf-1、Caspase-9的表达变化及意义

Expression and clinical significance of Apaf-1 and Caspase-9 in basal-like breast carcinoma
暂未订购
导出
摘要 目的观察基底细胞样乳腺癌(BLBC)组织中凋亡蛋白酶活化因子1(Apaf-1)、细胞凋亡蛋白酶9(Caspase-9)的表达变化,并探讨其意义。方法采用免疫组化法检测43例BLBC(A组)、57例non-BLBC(B组)和60例癌旁正常乳腺组织(C组)Apaf-1、Caspase-9的表达,分析两指标间及与BLBC临床病理参数的关系。结果A、B、C组Apaf-1阳性率分别为23.3%(10/43)、49.1%(28/57)、75%(45/60),两两比较,P均<0.01;Caspase-9阳性率分别为27.9%(12/43)、54.4%(31/57)、85%(51/60),两两比较,P均<0.01。Apaf-1表达与BLBC肿瘤直径、淋巴结转移、临床分期有关(P均<0.05),Caspase-9表达与BLBC淋巴结转移、临床分期有关(P均<0.05)。BLBC组织Apaf-1与Caspase-9阳性表达呈正相关(r=0.639,P<0.01)。结论 BLBC组织Apaf-1、Caspase-9表达降低,两者异常表达可能与BLBC的发生、发展密切相关。 Objective To observe the changes of Apaf-1, Caspase-9 expression in the basal-like breast cancer ( BLBC) tissues and explore its clinical significance.Methods The expressions of Apaf-1 and Caspase-9 were detected in 43 cases of BLBC( group A) , 57 cases of non-BLBC( group B) and 60 cases of normal breast tissue( group C) by immuno-histochemistry.The relationship between Apaf-1, Caspase-9 expression and clinicopathological features were analyzed.The correlation between Apaf-1 and Caspase-9 expression was analyzed.Results The positive expression rate of Apaf-1 in group A, B, C was 23.3%(10/43), 49.1%(28/57), 75%(45/60) respectively.The difference between each group was significant(all P〈0.01).The positive expression rate of Caspase-9 in group A, B, C was 27.9%(12/43), 54.4%(31/57), 85%(51/60) respectively.The difference between each group was all significant(all P〈0.01).The expres-sion of Apaf-1 was significantly correlated with the size of tumor, lymph nodes metastasis and the tumor clinical stage( all P〈0.05) .The expression of Caspase-9 was significantly correlated with lymph nodes metastasis and the tumor clinical stage (all P〈0.05).There correlation between the expression of Apaf-1 and Caspase-9 was significant(r=0.636, P〈0.01). Conclusions Apaf-1 and Caspase-9 are lower expressed in BLBC.The abnormal expression of Apaf-1 and Caspase-9 may be closely correlated with the carcinogenesis and development of BLBC.
出处 《山东医药》 CAS 2014年第39期12-14,共3页 Shandong Medical Journal
基金 河北省卫生厅医学科学研究课题(20130333)
关键词 乳腺肿瘤 基底细胞样乳腺癌 凋亡蛋白酶活化因子1 细胞凋亡蛋白酶9 breast neoplasms basal-like breast cancer apoptotic protease activating factor 1 Caspase-9
  • 相关文献

参考文献15

  • 1刘起胜.老年乳腺癌GSTπ、p53表达与淋巴结转移的相关性研究[J].中国煤炭工业医学杂志,2010,13(10):1457-1458. 被引量:4
  • 2Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [J]. Proc Natl Acad Sci USA, 2003,100(14) :8418-8423.
  • 3Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review [ J]. JC lin Oneol, 2008,26(15) :2568-2581.
  • 4Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer sub- types, and survival in the Carolina Breast Cancer Study [ J ]. JA- MA, 2006,295 (21) :2492- 2502.
  • 5Kim MJ, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes [ J ]. Hum Pathol, 2006,37 ( 9 ) : 1217-1226.
  • 6Yang XR, Sherman ME, Rimm DL, et al. Differences in risk fac- tors for breast cancer molecular subtypes in a population-based study[J]. Cancer Epidemiol. Biomarkers Prey, 2007,16(3) :439-.
  • 7王艳阳,折虹,丁喆,詹文华.Basal-like型乳腺癌临床特征与生存分析[J].肿瘤防治研究,2012,39(2):177-180. 被引量:4
  • 8Ruiz-Vela A, Korsmeyer SJ. Proapoptolic histone H1.2 induces CASP-3 and -7 activation by forming aprotein complex with CYT c, APAF-1 and CASP-9 [ J]. FEBS Lett, 2007,58 (1) :3422-3428.
  • 9Orzaez M, Mondragon L, Marzo I, et al. Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: ef- fective methods to improve inhibition of mitoehondria-mediated ap- optosis[J]. Peptides, 2007,2(8) :958-968.
  • 10Ashraf QM, Mishra OP, Delivoria-Papadopoulos M. Mechanisms of expression of apoptotie protease activating factor-1 ( Apaf-1 ) in nu- clear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn piglets[ J]. Neurosci Lett, 2007,41 (5) :253-258.

二级参考文献63

  • 1岑延增,罗云生,孙涛,马小干.细胞凋亡相关基因bcl-2与bax在胃癌组织中表达探讨[J].广西医科大学学报,2005,22(2):206-209. 被引量:9
  • 2文亚渊,刘宝华,付涛.胃癌组织中survivin,caspase-3和caspase-9基因表达的变化[J].第三军医大学学报,2005,27(21):2194-2195. 被引量:8
  • 3Hubert E Blum.Hepatocellular carcinoma: Therapy and prevention[J].World Journal of Gastroenterology,2005,11(47):7391-7400. 被引量:28
  • 4陈永初.病理生理学[M].北京:人民卫生出版社,2001:69-71.
  • 5Ayman S, Srinivasa MS, Samir A, et al. Cytochromec and dATP-mediated oligomerization of apaf-1 is a prerequisite for procaspase-9 activation [ J ]. The Journal of Biological Chemistry, 1999 ( 25 ) : 17 - 18.
  • 6Kelekar A, Thompson CB. bcl-2-family proteins: the role of the BH3 domain in apoptosis [ J ]. Trends Cell Biol, 1998 ( 8 ) :324 - 325.
  • 7Park IC, Park Mj, Hwang CS, et al. Mitomycin C induces apoptosis in a caspase-dependnt and Fas/CD95-independent manner in human gastric adenocarcinoma cells [ J ]. Cancer Lett ,2000 ( 2 ) : 125 - 132.
  • 8Li X, Marani M, Yu J, et al. Adenovirus-mediated bax over expression for the induction of therapeutic apoptosis in prostate cancer [ J ]. CancerRes, 2001 ( 61 ) : 1862 - 1863.
  • 9Yu JL, Rak JW, Coomber BL, et al. Effectof p53 status on tumor response to antiangiogenic therapy[ J]. Science, 2002 (5559) : 1526 - 1528.
  • 10Krajewski S, Blomqvist C, Franssila K, et al. Reduced expression of proapoptoticgene bax is associated with poor response rates to combination chemotherapyand shorter survival in woman with metastatic breast adenoearcinoma[J]. Cancer Res,1995(55) :4471 -4472.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部